FUNDAMENTALS
EdgeFII/DII
MOLBIOMolbio Diagnostics Ltd
₹1,495.50-2.02%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
MOLBIONSE · EquityHealthcare

Molbio Diagnostics Ltd

ISIN
INE869T01028
Instrument key
NSE_EQ|INE869T01028
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹1,495.50-30.90 · -2.02%
Day rangecircuit ₹1,196.40 – ₹1,794.60
1,483.10
1,580.00

as of 21/11/2026, 11:41:42 am

Open
₹1,549.80
Day high
₹1,580.00
Day low
₹1,483.10
Prev. close
₹1,526.40
Volume
7.01 L
VWAP
₹1,530.99

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

6 months · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M
1Y
5Y
MAX
Change · 6M
+43.56%
1,041.70 → 1,495.50
Period high
₹1,686.80
11/9/2026
Period low
₹926.35
17/8/2026
From high
-11.34%
+61.44% from low
Avg volume
25.86 L
17.33 Cr total
Volatility · ann.
83.1%
67 candles · 28 up / 39 down
20 Nov 2026O 1,549.80H 1,580.00L 1,483.10C 1,495.50Vol 7.01 L
SMA 20SMA 50Averages need 50 candles before they begin
Candle data67 rows of open, high, low, close and volumeShowHide
20 Nov 20261,549.801,580.001,483.101,495.50-3.50%96.907.01 L
19 Nov 20261,505.001,540.201,477.001,526.40+1.42%63.204.63 L
18 Nov 20261,499.001,517.301,458.001,497.60-0.09%59.303.57 L
17 Nov 20261,488.001,541.301,473.201,484.10-0.26%68.104.88 L
16 Nov 20261,510.001,529.901,475.101,486.40-1.56%54.805.67 L
13 Nov 20261,412.601,545.001,394.101,493.20+5.71%150.9023.04 L
12 Nov 20261,323.001,482.001,323.001,394.10+5.37%159.0022.77 L
11 Nov 20261,336.001,360.001,307.001,318.60-1.30%53.004.25 L
9 Nov 20261,357.301,370.601,322.201,336.00-1.57%48.401.54 L
8 Nov 20261,350.601,406.001,342.201,360.20+0.71%63.801.15 L

Historical price and volume data · Showing 1–10 of 67

1 / 7

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

121.64
Company
121.64
Sector
39.99

Worse than sector by 204%

P/B

Price ÷ book value per share

11.96
Company
11.96
Sector
4.0

Worse than sector by 199%

ROA

Net income ÷ total assets

6.08%
Company
6.08%
Sector
10.51%

Worse than sector by 42%

ROE

Net income ÷ shareholders' equity

10.72%
Company
10.72%
Sector
17.51%

Worse than sector by 39%

ROCE

EBIT ÷ capital employed

13.62%
Company
13.62%
Sector
18.73%

Worse than sector by 27%

Quick Ratio

Liquid assets ÷ current liabilities

1.68
Company
1.68
Sector
2.72

Worse than sector by 38%

EV/EBITDA

Enterprise value ÷ EBITDA

53.01
Company
53.01
Sector
14.77

Worse than sector by 259%

04/Business

About the company

Sector: Healthcare

Sector market cap (INR)
₹17,228 Cr

reported in crore

Sector market cap (USD)
$1.91B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹1,455 Cr
+41.56% vs Mar 2025
Net profit · Mar 2026
₹164 Cr
+18.44% vs Mar 2025
Operating margin
15.9%
was 18.9%
Revenue CAGR · 4p
62.8%
profit — · op 189.4%
Filed order
Revenue1,4551,028841337
Revenue growthreported41.6%22.3%149.2%—
Operating profit23119413010
Operating profit growthreported18.9%50.0%1258.9%—
Operating marginderived15.9%18.9%15.4%2.8%
Net profit16413984-3
Net profit growthreported18.4%65.9%2521.4%—
Net marginderived11.3%13.5%9.9%-1.0%
EPS — basic₹/share, annual14.7712.879.05-0.06

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹2,148 Cr
+46.99% YoY
Total liabilities
₹840 Cr
Net worth
₹1,309 Cr
Liabilities ÷ assets
39.1%
lower means a lighter balance sheet
Filed order
Total assets2,1481,4621,2211,034
Total liabilities840494392297
Net worthderived1,309967829737
Liabilities ÷ assetsderived39.1%33.8%32.1%28.7%
Asset growthderived47.0%19.7%18.1%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets764532398423
Current Assets1,385930823611
Total Assets2,1481,4621,2211,034
Current Liabilities557442343258
Net Current Asset827488480354
Non-Current Liabilities282534939
Equity Capital1,309967829737
Total Equity & Liabilities2,1481,4621,2211,034

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹50 Cr
-82.45% YoY
Investing
-₹93 Cr
Financing
₹276 Cr
Free cash flow
-₹43 Cr
operating + investing
Filed order
Operating activities502871064
Operating changereported-82.5%2900.0%-85.1%—
Investing activities-93-123-45-40
Investing changereported24.0%-172.5%-13.3%—
Financing activities276-26-3218
Financing changereported1155.7%17.1%-273.0%—
Net cash flowderived233138-6743
Free cash flowoperating + investing-43164-3524

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax23119413010
Income before WC changes35328527347
Change in Assets-257-55-25220
Change in Liabilities251373235
Change in WC-23282-22055
Cash flow from Operations502871064
Cash flow from Investing-93-123-45-40
Cash flow from Financing276-26-3218
Total Cash Flow233138-6743
Cash (Start of the year)63-75-8-51
Cash (End of the year)33663-75-8

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 3 reported quarters. Sort any quarter column to rank holders by size.

Promoters
41.29%
0.00 pts QoQ
FII
1.59%
+0.08 pts QoQ
DII (other)
11.06%
-3.06 pts QoQ
Mutual funds
8.03%
+5.78 pts QoQ
Retail & others
38.03%
-2.79 pts QoQ
Filed order
Promoters41.3%41.3%46.6%
FII1.6%1.5%0.0%
DII (other)11.1%14.1%0.0%
Mutual funds8.0%2.3%0.0%
Retail & others38.0%40.8%53.4%
Promoters — QoQ changepts, derived0.0%-5.4%—
FII — QoQ changepts, derived0.1%1.5%—
DII (other) — QoQ changepts, derived-3.1%14.1%—
Mutual funds — QoQ changepts, derived5.8%2.3%—
Retail & others — QoQ changepts, derived-2.8%-12.5%—
Totalderived100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

No corporate actions on record

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue1,4461,020837332
Other Income9845
Total Revenue1,4551,028841337
Total Expenses1,221820658328
Profit Before Tax23119413010
Tax67564613
Profit After Tax16413984-3
EPS - Basic14.7712.879.05-0.06
EPS - Diluted14.7712.879.04-0.06

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.